The value of cerebrospinal fluid lactate levels in diagnosing CSF infections in pediatric neurosurgical patients.


Journal

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
ISSN: 1433-0350
Titre abrégé: Childs Nerv Syst
Pays: Germany
ID NLM: 8503227

Informations de publication

Date de publication:
07 2019
Historique:
received: 20 03 2019
accepted: 16 04 2019
pubmed: 9 5 2019
medline: 30 9 2020
entrez: 9 5 2019
Statut: ppublish

Résumé

Diagnosis of cerebrospinal fluid (CSF) infections in patients following neurosurgical procedures can be challenging. CSF lactate (LCSF) has been shown to assist in differentiating bacterial from non-bacterial meningitis in non-neurosurgical patients. The use of lactate in diagnosing CSF-related infections following neurosurgical procedures has been described in adults. The goal of this study was to describe the role of LCSF levels in diagnosing CSF-related infections among neurosurgical children. We retrospectively collected data for all pediatric patients treated at a large tertiary pediatric neurosurgical department, for whom CSF samples were collected over a 2-year period. Lactate levels were correlated with other CSF parameters, surgical parameters, presence of CSF infection, and source of CSF sample (lumbar, ventricular, or pseudomeningocele). A total of 215 CSF samples from 162 patients were analyzed. We found a correlation between lactate levels and other CSF parameters. Lactate levels displayed an inconsistent correlation with infection depending on sample origin. Irrespective of the CSF source, lactate levels could not sufficiently discriminate between those with or without infection. Lactate levels were correlated with recent surgery, and, in some of the subgroups, to the extent of blood in CSF. LCSF levels are influenced by many factors, including the source of sample, recent surgery, and the presence of subarachnoid or ventricular blood secondary to surgery. The added value of LCSF for diagnosing CSF infections in children with a history of neurosurgical procedures is unclear and may be influenced by the extent of blood in the CSF.

Identifiants

pubmed: 31065782
doi: 10.1007/s00381-019-04163-7
pii: 10.1007/s00381-019-04163-7
doi:

Substances chimiques

Lactic Acid 33X04XA5AT

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1147-1153

Références

Clin Infect Dis. 1999 Jul;29(1):69-74
pubmed: 10433567
Clin Infect Dis. 2001 Jan 15;32(2):179-85
pubmed: 11170905
Stroke. 1975 Nov-Dec;6(6):707-14
pubmed: 1198637
Neurology. 1975 Oct;25(10):943-8
pubmed: 1237104
Crit Care Resusc. 2003 Sep;5(3):177-81
pubmed: 16573479
Arq Neuropsiquiatr. 2006 Sep;64(3A):592-5
pubmed: 17119799
Acta Med Croatica. 1991;45(4-5):341-5
pubmed: 1726518
J Clin Neurosci. 2008 Jun;15(6):654-5
pubmed: 18342513
Crit Care. 2010;14(6):R240
pubmed: 21194480
J Infect. 2011 Apr;62(4):255-62
pubmed: 21382412
Crit Care. 2011;15(3):R136
pubmed: 21645387
Neurocirugia (Astur). 2012 Jul;23(4):131-5
pubmed: 22704649
Clin Neurol Neurosurg. 2013 Sep;115(9):1820-5
pubmed: 23810183
Clin Biochem. 2015 Jan;48(1-2):50-4
pubmed: 25445228
BMC Infect Dis. 2016 Sep 13;16:483
pubmed: 27618955
Clin Infect Dis. 2017 Feb 14;:
pubmed: 28203777
Int J Infect Dis. 2017 Jun;59:50-54
pubmed: 28392319
J Neurol Neurosurg Psychiatry. 1989 Mar;52(3):372-5
pubmed: 2926423
J Neurosurg. 1988 Nov;69(5):669-74
pubmed: 3183729
Lancet. 1967 May 6;1(7497):965-7
pubmed: 4164600
Neurology. 1972 Jun;22(6):585-9
pubmed: 4673334
J Neurosurg. 1974 Jul;41(1):44-8
pubmed: 4834194
J Infect Dis. 1978 Apr;137(4):384-90
pubmed: 649985
Stroke. 1983 Nov-Dec;14(6):960-3
pubmed: 6659001
Arch Intern Med. 1983 Jan;143(1):85-7
pubmed: 6849611
Neurosurg Clin N Am. 1994 Oct;5(4):741-54
pubmed: 7827482
Neurology. 1975 Oct;25(10):935-42
pubmed: 809724
Stroke. 1975 Nov-Dec;6(6):715-9
pubmed: 822

Auteurs

Jonathan Roth (J)

Department of Pediatric Neurosurgery, Dana Children's Hospital, Tel Aviv Medical Center, Tel Aviv University, 6 Weizman Street, Tel Aviv-Yafo, Israel. jonaroth@gmail.com.

Jehuda Soleman (J)

Department of Pediatric Neurosurgery, Dana Children's Hospital, Tel Aviv Medical Center, Tel Aviv University, 6 Weizman Street, Tel Aviv-Yafo, Israel.

Danil A Kozyrev (DA)

Department of Pediatric Neurosurgery, Dana Children's Hospital, Tel Aviv Medical Center, Tel Aviv University, 6 Weizman Street, Tel Aviv-Yafo, Israel.

John N Jabang (JN)

Department of Pediatric Neurosurgery, Dana Children's Hospital, Tel Aviv Medical Center, Tel Aviv University, 6 Weizman Street, Tel Aviv-Yafo, Israel.

Maya Stein (M)

Department of Pediatric Neurosurgery, Dana Children's Hospital, Tel Aviv Medical Center, Tel Aviv University, 6 Weizman Street, Tel Aviv-Yafo, Israel.

Galia Grisaru-Soen (G)

Pediatric Infectious Disease Unit, Dana Children's Hospital, Tel Aviv Medical Center, Tel Aviv University, Tel Aviv-Yafo, Israel.

Haggai Benvenisti (H)

Department of Pediatric Neurosurgery, Dana Children's Hospital, Tel Aviv Medical Center, Tel Aviv University, 6 Weizman Street, Tel Aviv-Yafo, Israel.

Efraim Sadot (E)

Pediatric Intensive Care Unit, Dana Children's Hospital, Tel Aviv Medical Center, Tel Aviv University, Tel Aviv-Yafo, Israel.

Shirley Friedman (S)

Pediatric Intensive Care Unit, Dana Children's Hospital, Tel Aviv Medical Center, Tel Aviv University, Tel Aviv-Yafo, Israel.

Itay Ayalon (I)

Pediatric Intensive Care Unit, Dana Children's Hospital, Tel Aviv Medical Center, Tel Aviv University, Tel Aviv-Yafo, Israel.

Ilana Goldiner (I)

Clinical Biochemistry and Pharmacology laboratory, Tel Aviv Medical Center, Tel Aviv, Tel Aviv-Yafo, Israel.

Moshe Stark (M)

Clinical Biochemistry and Pharmacology laboratory, Tel Aviv Medical Center, Tel Aviv, Tel Aviv-Yafo, Israel.

Eyal Hassoun (E)

Clinical Biochemistry and Pharmacology laboratory, Tel Aviv Medical Center, Tel Aviv, Tel Aviv-Yafo, Israel.

Shlomi Constantini (S)

Department of Pediatric Neurosurgery, Dana Children's Hospital, Tel Aviv Medical Center, Tel Aviv University, 6 Weizman Street, Tel Aviv-Yafo, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH